Chromatin modifiers - Coordinators of estrogen action

Area of Science:

• Endocrinology
• Molecular Biology
• Cancer Research

Background:

• Estrogens are crucial hormones regulating physiological functions and implicated in cancer development.
• Two main estrogen receptor (ER) isoforms, ERα and ERβ, mediate distinct cellular responses.
• ER subtype expression and co-regulator interactions are vital in cancer progression.

Purpose of the Study:

• To review the role of estrogen receptors (ERs) in physiological and pathophysiological processes, particularly cancer.
• To elucidate the complex interplay between ERs, co-regulators, and chromatin modifiers.
• To discuss the contribution of chromatin accessibility and epigenetic modifications to ER function.

Main Methods:

• Literature review focusing on estrogen receptor signaling.
• Analysis of the role of co-regulators in ER-mediated transcription.
• Examination of epigenetic modifications and chromatin remodeling in ER activity.

Main Results:

• Estrogen receptor activity is modulated by tissue-specific co-regulators, influencing transcriptional outcomes.
• Co-regulators, including epigenetic enzymes and chromatin remodelers, form complexes with ERs.
• Chromatin accessibility and epigenetic marks dictate ER binding and transcriptional activation.

Conclusions:

• Estrogen receptor function in cancer is intricately linked to co-regulator complexes and epigenetic regulation.
• Understanding ER-chromatin modifier interactions is crucial for deciphering ER-driven cancer biology.
• Epigenetic modifications play a significant role in ER recruitment and transactivation, impacting cancer development.